Stay on the course... for Trek is going to see the full impact of its Rely/Mattel deal supplying wireless Flu-card modules. I think FY15 will be thumbs - up.
The rise and rise of the stock price --- resulting in 45 cents level breached. TREK is entering a high growth stage with its FluCard finding customers and more applications, Yes!
I would not buy on historical earnings and on NTA. However, with a little stretch of the imagination and a dose of confidence in the company & its patents, I would buy on a pullback to below 40 cents.